Will 2023 be the year that pharma M&A makes a comeback? By: MarketWatch January 12, 2023 at 13:29 PM EST A handful of acquisitions this week point to a more deal-friendly year for biopharma and biotech companies. Read More >> Related Stocks: Albireo Pharma Inc Amgen Amryt Pharma Plc ADR Apellis Pharmaceuticals Inc Astrazeneca Plc ADR Biontech Se ADR CinCor Pharma, Inc. - Common Stock Horizon Therapeutics Karuna Therapeutics Inc S&P Biotech SPDR S&P Pharmaceuticals SPDR Xenon Pharmaceuticals Inc
